ASP Isotopes (NASDAQ:ASPI) Announces Earnings Results

ASP Isotopes (NASDAQ:ASPI) issued its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11), Zacks reports. The business had revenue of $5.12 million during the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

ASP Isotopes Trading Up 1.9%

ASPI stock opened at $2.70 on Friday. ASP Isotopes has a 12-month low of $2.51 and a 12-month high of $14.49. The business’s 50-day moving average is $3.72 and its 200 day moving average is $4.89. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. The stock has a market cap of $413.94 million, a price-to-earnings ratio of -2.05 and a beta of 3.70.

Analysts Set New Price Targets

Several research analysts have recently weighed in on ASPI shares. Wall Street Zen raised ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, ASP Isotopes currently has an average rating of “Hold” and a consensus target price of $13.00.

Insider Buying and Selling at ASP Isotopes

In other news, Director John Ryan bought 15,000 shares of the firm’s stock in a transaction dated Wednesday, September 30th. The shares were acquired at an average price of $2.68 per share, for a total transaction of $40,200.00. Following the completion of the transaction, the director directly owned 675,222 shares in the company, valued at $1,809,594.96. The trade was a 2.27% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Paul Mann sold 83,759 shares of ASP Isotopes stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $4.10, for a total value of $343,411.90. Following the completion of the sale, the chief executive officer directly owned 9,328,570 shares in the company, valued at $38,247,137. This represents a 0.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 200,955 shares of company stock valued at $804,605 over the last quarter. 14.40% of the stock is currently owned by insiders.

ASP Isotopes Company Profile

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage company focused on isotope enrichment and related technologies. The company is developing an isotope-separation platform known as the Aerodynamic Separation Process, which is intended to enrich selected chemical elements and isotopes for use in several specialized markets.

ASP Isotopes has identified applications in the nuclear energy, medical, semiconductor, and quantum-computing industries. Its development programs have included uranium enrichment as well as the production of specialty isotopes such as carbon-14, molybdenum-100, and silicon-28.